Product correctly added to cart.

discount label
ML417
View 3D

Biosynth logo

ML417

CAS: 1386162-69-1

Ref. 3D-LFC16269

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Friday 12 Jul 2024

Product Information

Name:
ML417
Description:

ML417 is a novel, non-peptide, high-affinity dopamine D2 receptor agonist that has been shown to be a potent functional ligand in the rat and monkey. It has been shown to increase dopamine levels in the central nervous system. ML417 also blocks the binding of [3H]spiperone to the human D2 receptor with an affinity similar to that of quinpirole (a reference high-affinity D2 receptor agonist). The compound has been shown to have clinical relevance in animal models of myocardial infarct and in behavioral assays for antipsychotic activity. In vitro studies have revealed that ML417 has biochemical properties consistent with those observed for other dopamine receptor ligands. These include binding to d2/d3 receptors and inhibition of adenylyl cyclase activity. Molecular modeling studies have demonstrated that ML417 is a high-affinity molecule for the dopamine D2 receptor with a favorable pharmacokinetic profile.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
379.5 g/mol
Formula:
C22H25N3O3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-LFC16269 ML417

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".